Ziemowit Pokladek’s Post

I am thrilled to share our recent publication entitled "Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay" in Medical Oncology Journal, Q2 Thanks for the whole team https://lnkd.in/dYRBB_zF

We have presented our abstract in Breastanbul’24 entitled “Real-life use and decision impact of Mammaprint on clinical practice in early breast cancer: A multicenter Turkish Oncology Group Study.”

Breast cancer is a leading cause of mortality and morbidity worldwide. This article reviews the current landscape of neoadjuvant therapy for HR+/HER2- breast cancer, focusing on #biomarkers for decision making, and exploring next steps of #clinicalresearch in this therapeutic space. #oncologyclinicaltrials

A pooled analysis exploring tumor intrinsic subtypes in 3 trials on HER2+ EBC - Elisa Agostinetto JAMA Oncology OncoAlert #BreastCancer #Research #Cancer #HER2E #JAMAOncology #OncoDaily #Oncology #PCR #TumorSubtypes

Another important publication demonstrating Fortrea's leadership across oncology clinical development. Breast cancer is a leading cause of mortality and morbidity worldwide. This article reviews the current landscape of neoadjuvant therapy for HR+/HER2- breast cancer, focusing on #biomarkers for decision making, and exploring next steps of #clinicalresearch in this therapeutic space. #oncologyclinicaltrials

Brilliantly designed I-SPY2 trial - adaptive neoadjuvant treatments for early breast cancer, stratified by receptor status, DNA repair deficiency & immunogenicity and tailored according to predicted response. The ADC/IO synergy continues to grow & this trial could really set the platform for personalised de-escalation & intensification approaches. Great abstract at #ESMO24. https://lnkd.in/egvFU62r ESMO - European Society for Medical Oncology

The Growth Inhibition Effect of Different Extracts of Taraxacum Peregrinum Leaves on Breast Cancer Cell Line MDA-MB-468

Breast cancer is a leading cause of mortality and morbidity worldwide. This article reviews the current landscape of neoadjuvant therapy for HR+/HER2- breast cancer, focusing on #biomarkers for decision making, and exploring next steps of #clinicalresearch in this therapeutic space. #oncologyclinicaltrials

👉 👉 👉 The future of medical oncology will focus on understanding cancer biology and intercepting the disease before it appears or recurs. In this new podcast of #TJTalks, prof. Giuseppe Curigliano, chair of the Division of Early Drug Development at the IEO European Institute of Oncology in Milan, and professor at the Università degli Studi di Milano, talks with prof. Pruneri Giancarlo about the future of #precisiononcology and his commitment as President- elect of ESMO - European Society for Medical Oncology 🔗 https://lnkd.in/ddcBtKfr #Oncology #CancerResearch #CancerCare #Medicine #ScientificCommunication #ResearchImpact #Patients #CancerTherapy #EvidencedBasedResearch #Cancer

The Growth Inhibition Effect of Different Extracts of Taraxacum Peregrinum Leaves on Breast Cancer Cell Line MDA-MB-468